Genetic and post-mortem mRNA analysis of the 14-3-3 genes that encode phosphoserine/threonine-binding regulatory proteins in schizophrenia and bipolar disorder

Schizophrenia Research - Tập 78 - Trang 137-146 - 2005
Albert H.C. Wong1,2,3,4, Olga Likhodi1, Joseph Trakalo1, Muneeb Yusuf4, Anuradha Sinha1, Carlos N. Pato5,6, Michele T. Pato5,6, Hubert H.M. Van Tol1,2,3,4, James L. Kennedy1,2,4
1Centre for Addiction and Mental Health, Faculty of Medicine, University of Toronto, Canada
2Department of Psychiatry, Faculty of Medicine, University of Toronto, Canada
3Department of Pharmacology, Faculty of Medicine, University of Toronto, Canada
4Institute of Medical Science, Faculty of Medicine, University of Toronto, Canada
5Upstate Medical Center, Research Division, State University of New York, Syracuse, NY, USA
6VAMC, Washington, DC, USA

Tài liệu tham khảo

Aitken, 1995, 14-3-3 proteins: biological function and domain structure, Biochem. Soc. Trans., 23, 605, 10.1042/bst0230605 Amati, 1999, Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo–cardio–facial syndrome, Eur. J. Hum. Genet., 7, 903, 10.1038/sj.ejhg.5200399 1994 Badner, 2002, Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia, Mol. Psychiatry, 7, 405, 10.1038/sj.mp.4001012 Bell, 2000, Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia, Am J Med Genet, 96, 736, 10.1002/1096-8628(20001204)96:6<736::AID-AJMG8>3.0.CO;2-2 Benjamini, 2001, Controlling the false discovery rate in behavior genetics research, Behav. Brain Res., 125, 279, 10.1016/S0166-4328(01)00297-2 Chowdari, 2002, Association and linkage analyses of RGS4 polymorphisms in schizophrenia, Hum. Mol. Genet., 11, 1373, 10.1093/hmg/11.12.1373 Chumakov, 2002, Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia, Proc. Natl. Acad. Sci. U. S. A., 99, 13675, 10.1073/pnas.182412499 Coon, 1994, Genomic scan for genes predisposing to schizophrenia, Am. J. Med. Genet., 54, 59, 10.1002/ajmg.1320540111 Culverhouse, 2002, A perspective on epistasis: limits of models displaying no main effect, Am. J. Hum. Genet., 70, 461, 10.1086/338759 Fu, 2000, 14-3-3 proteins: structure, function, and regulation, Annu. Rev. Pharmacol. Toxicol., 40, 617, 10.1146/annurev.pharmtox.40.1.617 Gill, 1996, A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12, Am. J. Med. Genet., 67, 40, 10.1002/(SICI)1096-8628(19960216)67:1<40::AID-AJMG6>3.0.CO;2-W Horvath, 2004, Family-based tests for associating haplotypes with general phenotype data: application to asthma genetics, Genet. Epidemiol., 26, 61, 10.1002/gepi.10295 Lahiri, 1991, A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies, Nucleic Acids Res., 19, 5444, 10.1093/nar/19.19.5444 Laird, 2000, Implementing a unified approach to family-based tests of association, Genet. Epidemiol., 19, S36, 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M Liu, 2002, Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia, Proc. Natl. Acad. Sci. U. S. A., 99, 3717, 10.1073/pnas.042700699 Maxwell, 1992 McIntyre, 2000, Circumventing multiple testing: a multilocus Monte Carlo approach to testing for association, Genet. Epidemiol., 19, 18, 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y Middleton, 2005, Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia, Neuropsychopharmacology, 30, 974, 10.1038/sj.npp.1300674 Morgan, 1992, Exo1 and Exo2 proteins stimulate calcium-dependent exocytosis in permeabilized adrenal chromaffin cells, Nature, 355, 833, 10.1038/355833a0 Muratake, 1996, Structural organization and chromosomal assignment of the human 14-3-3 eta chain gene (YWHAH), Genomics, 36, 63, 10.1006/geno.1996.0426 Murphy, 1999, High rates of schizophrenia in adults with velo–cardio–facial syndrome, Arch. Gen. Psychiatry, 56, 940, 10.1001/archpsyc.56.10.940 Muslin, 2000, 14-3-3 proteins: regulation of subcellular localization by molecular interference, Cell. Signal., 12, 703, 10.1016/S0898-6568(00)00131-5 Nurnberger, 1994, Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative, Arch. Gen. Psychiatry, 51, 849, 10.1001/archpsyc.1994.03950110009002 Ott, 2003, Set association analysis of SNP case-control and microarray data, J. Comput. Biol., 10, 569, 10.1089/10665270360688192 Peng, 1997, Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216, Science, 277, 1501, 10.1126/science.277.5331.1501 Pulver, 1994, Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22q12–q13.1: Part 1, Am. J. Med. Genet., 54, 36, 10.1002/ajmg.1320540108 Rosenberg, 2002, Genetic structure of human populations, Science, 298, 2381, 10.1126/science.1078311 Schwab, 1999, Chromosome 22 workshop report, Am. J. Med. Genet., 88, 276, 10.1002/(SICI)1096-8628(19990618)88:3<276::AID-AJMG13>3.0.CO;2-N Shifman, 2002, A highly significant association between a COMT haplotype and schizophrenia, Am. J. Hum. Genet., 71, 1296, 10.1086/344514 Skoulakis, 1998, 14-3-3 proteins in neuronal development and function, Mol. Neurobiol., 16, 269, 10.1007/BF02741386 Spielman, 1998, A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test, Am. J. Hum. Genet., 62, 450, 10.1086/301714 Spielman, 1993, Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM), Am. J. Hum. Genet., 52, 506 Stefansson, 2002, Neuregulin 1 and susceptibility to schizophrenia, Am. J. Hum. Genet., 71, 877, 10.1086/342734 Straub, 2002, Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia, Am. J. Hum. Genet., 71, 337, 10.1086/341750 Torrey, 2000, The Stanley Foundation brain collection and neuropathology consortium, Schizophr. Res., 44, 151, 10.1016/S0920-9964(99)00192-9 Toyooka, 1999, 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia, Am. J. Med. Genet., 88, 164, 10.1002/(SICI)1096-8628(19990416)88:2<164::AID-AJMG13>3.0.CO;2-3 Tzivion, 2001, 14-3-3 proteins; bringing new definitions to scaffolding, Oncogene, 20, 6331, 10.1038/sj.onc.1204777 Vawter, 2001, Application of cDNA microarrays to examine gene expression differences in schizophrenia, Brain Res. Bull., 55, 641, 10.1016/S0361-9230(01)00522-6 Wong, 2003, Schizophrenia: from phenomenology to neurobiology, Neurosci. Biobehav. Rev., 27, 269, 10.1016/S0149-7634(03)00035-6 Wong, 2003, Identification of candidate genes for psychosis in rat models, and possible association between schizophrenia and the 14-3-3eta gene, Mol. Psychiatry, 8, 156, 10.1038/sj.mp.4001237 Yaffe, 2002, How do 14-3-3 proteins work?—gatekeeper phosphorylation and the molecular anvil hypothesis, FEBS Lett., 513, 53, 10.1016/S0014-5793(01)03288-4